Navigation Links
VMAT2 in Medical News

Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results

...lly completed, and we advanced another compound, a vmat2 inhibitor, now ready for clinical development. We ...noamine Transporter 2 Inhibitor (VMAT2 ) vmat2 is a protein concentrated in the human brain that ...ons. The Company has identified a highly selective vmat2 inhibitor that is effective in regulating the leve...

FDA Advisory Committee Votes Unanimously to Recommend Approval of Tetrabenazine for Chorea Associated With Huntington Disease

... associated with HD. A highly selective and reversible centrally-acting dopamine depleting drug, tetrabenazine works by inhibiting a molecule known as vmat2 (vesicular monoamine transporter 2). Adverse events reported with tetrabenazine, most of which were addressed by titrating down the dose, included d...
VMAT2 in Biological Technology

Neurocrine Biosciences Reports Second Quarter 2009 Results

...h is elagolix, and have just put another compound, vmat2 inhibitor into Phase I trials. We also continue t...ent; enrollment of 50 subjects is planned. vmat2 Update The highly selective blockade of the Ves...including risk that the Company's urocortin 2, and vmat2 clinical candidates will not proceed to later stag...

Neurocrine Biosciences Reports First Quarter 2009 Results

...noamine Transporter 2 Inhibitor (VMAT2 ) vmat2 is a protein concentrated in the human brain that ...neurons. Neurocrine identified a highly selective vmat2 inhibitor that is effective in regulating the leve...mpany's urocortin 2, CRF1 receptor antagonist, and vmat2 clinical candidates will not proceed to later stag...

Neurocrine Announces Work Force Restructuring

... are going to find continued success in their careers," said Kevin C. Gorman President & CEO. "We will maintain our efforts on elagolix, move our vmat2 program into the clinic, and focus on the other high value assets. We continue to conservatively manage our cash resources while advancing our pipeli...

Neurocrine Biosciences Reports Third Quarter 2008 Results

...studies of urocortin 2 to allow for long-term Phase II clinical studies and our scientists have just recently identified a clinical candidate from our vmat2 development program for movement disorders," said Kevin Gorman, Chief Executive Officer and President of Neurocrine Biosciences. "While we are making ...
VMAT2 in Biological Products

Anti-Vesicular Monoamine Transporter 2 (VMAT2) Polyclonal Antibody, Unconjugated from CHEMICON

Description:...rter 2 (VMAT2). An antibody made to the C-terminal vmat2 peptide detected a major band at ~55 kDa in postnuclear supernatants of CHO transfected with vmat2 and not in wild type cells (2). Some additional ba... molecular weight bands may represent glycosylated vmat2 (2,3)....
Company:CHEMICON
Other Tags
(Date:7/30/2015)... ... July 30, 2015 , ... ... video, “Beachside Nursing Center,” to announce its position as one of Medicare’s ... administrator and staff members support the CMS rating system, which monitors health ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ross A. Clevens, MD, FACS ... Assistant Professor of Plastic Surgery. This is Dr. Clevens’ second appointment by the ... the university, developing a strong presence and a valuable mentoring program for medical students. ...
(Date:7/30/2015)... ... , ... Using the latest online digital technologies, happiness expert Kay Walker is ... and manage major depression. , “Suicide is 100% preventable. The problem is the medical ... and die needlessly everyday,” says Walker. “I’m out to end suicide. Some may say ...
(Date:7/30/2015)... ... July 30, 2015 , ... Between 2012 and 2014 HIV infection ... News Florida on June 17th. Those untreated heroin use disorders share their needles ... spread of dirty needles throughout the community. Ultimately Florida’s HIV infection rates have bolstered ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Acting Administrator Chuck Rosenberg’s announcement of the reinstitution of National Prescription Drug Take-Back ... 26, 2015 from 10:00 AM to 2:00 PM local time. On the 26th, ...
Breaking Medicine News(10 mins):Health News:Beachside Nursing Center Releases New Video 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3
(Date:7/8/2015)... YORK , July 8, 2015 Summary ... globally, and the fourth most fatal, with a mortality ... The poor prognosis of pancreatic cancer patients has highlighted ... treatment, which is not being met by the current ... an array of products with varying molecule types and ...
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/7/2015)... DUBLIN , June 30, 2015 ... ) has announced the addition of the ... their offering. To this date, fingerprint ... biometric technology and fingerprint sensors are well developed. ... capacitive sensing technology. The domain of ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
Other Contents